Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Genet Mol Res ; 10(4): 2841-50, 2011 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-22095608

RESUMO

Regulated on activation, normal T-cell expressed and secreted (RANTES) and stromal cell-derived factor 1 (SDF-1) are members of the CC- and CXC-chemokine families, respectively. Both genes have been postulated to be involved in the pathogenesis of systemic lupus erythematosus (SLE). We analyzed position 28 of the RANTES gene promoter region, as well as the SNP observed in the 3' UTR of the SDF-1 gene at position 801, in 130 patients presenting SLE at the Malaya University Medical Centre. Screening of 130 healthy volunteer controls using RFLP was also performed. RANTES-28 polymorphism analysis showed no significant (P = 0.3520) relationship, even though homozygous C/C was more frequent in SLE patients (OR = 1.4183) and heterozygous C/G was more frequent in healthy controls (OR = 0.7051). There were no significant (P = 0.2650) associations between A/A (OR = 0.783), G/G (OR = 1.5914) and G/A (OR = 0.8289) genotypes in the SDF-1 gene polymorphism with SLE. We conclude that there is no significant association of RANTES-28 and SDF-1 gene polymorphisms and occurrence of SLE in Malaysia.


Assuntos
Quimiocina CCL5/genética , Quimiocina CXCL12/genética , Lúpus Eritematoso Sistêmico/genética , Polimorfismo de Fragmento de Restrição , Polimorfismo de Nucleotídeo Único , Regiões 3' não Traduzidas/genética , Adolescente , Adulto , Povo Asiático/etnologia , Povo Asiático/genética , Feminino , Humanos , Lúpus Eritematoso Sistêmico/epidemiologia , Lúpus Eritematoso Sistêmico/etnologia , Malásia/epidemiologia , Malásia/etnologia , Masculino , Pessoa de Meia-Idade , Regiões Promotoras Genéticas/genética
2.
Genet Mol Res ; 10(2): 739-43, 2011 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-21523653

RESUMO

Allele frequencies of 15 short tandem repeat (STR) loci, namely D5S818, D7S820, D13S317, D16S539, TH01, TPOX, Penta D, Penta E, D3S1358, D8S1179, D18S51, D21S11, CSF1PO, vWA, and FGA, were determined for 154 individuals from the Kadazan-Dusun tribe, an indigenous population of East Malaysia. All loci were amplified by polymerase chain reaction, using the Powerplex 16 system. Alleles were typed using a gene analyzer and the Genemapper ID software. Various statistical parameters were calculated and the combined power of discrimination for the 15 loci in the population was calculated as 0.999999999999999. These loci are thus, informative and can be used effectively in forensic and genetic studies of this indigenous population.


Assuntos
Frequência do Gene/genética , Repetições de Microssatélites , Alelos , Loci Gênicos , Genética Populacional , Humanos , Malásia/etnologia , Reação em Cadeia da Polimerase
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;42(6): 551-555, June 2009. ilus, tab
Artigo em Inglês | LILACS | ID: lil-512773

RESUMO

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that involves the inflammation of various organs upon deposition of immune complexes and is characterized by uncontrolled B cell hyperactivity. Despite intensive research on the etiology of the disease, the exact cause of the onset of SLE is unknown. The pathogenesis of the disease has been proposed to be associated with the imbalance of T helper type 1 (Th1) and Th2 cytokine activities. Elevated serum levels of interleukin-6 (IL-6), a Th2 cytokine with various functions in the regulation of human biological systems, are observed in SLE patients. In the present study, 100 Malaysian SLE patients and 100 controls were evaluated in order to determine the association of polymorphisms existing in the promoter region of the IL-6 gene with the onset of SLE. The homozygous G genotype was found to be significant in SLE patients (χ² = 33.754; P = 0.00000000625), whereas the heterozygous G/C genotype was significant in the controls (χ²= 25.087; P = 0.000000548). We suggest that the C allele might have a masking effect on the G allele when both alleles are present in heterozygous individuals. However, we did not observe any significant association of the homozygous C allele with the onset of SLE or with protection from the disease (χ² = 1.684; P = 0.194366).


Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , /genética , Lúpus Eritematoso Sistêmico/genética , Estudos de Casos e Controles , Frequência do Gene , Homozigoto , /sangue , Lúpus Eritematoso Sistêmico/sangue , Malásia , Reação em Cadeia da Polimerase , Regiões Promotoras Genéticas , Polimorfismo de Nucleotídeo Único/genética , Adulto Jovem
4.
Braz J Med Biol Res ; 42(6): 551-5, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19448905

RESUMO

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that involves the inflammation of various organs upon deposition of immune complexes and is characterized by uncontrolled B cell hyperactivity. Despite intensive research on the etiology of the disease, the exact cause of the onset of SLE is unknown. The pathogenesis of the disease has been proposed to be associated with the imbalance of T helper type 1 (Th1) and Th2 cytokine activities. Elevated serum levels of interleukin-6 (IL-6), a Th2 cytokine with various functions in the regulation of human biological systems, are observed in SLE patients. In the present study, 100 Malaysian SLE patients and 100 controls were evaluated in order to determine the association of polymorphisms existing in the promoter region of the IL-6 gene with the onset of SLE. The homozygous G genotype was found to be significant in SLE patients (chi(2) = 33.754; P = 0.00000000625), whereas the heterozygous G/C genotype was significant in the controls (chi(2)= 25.087; P = 0.000000548). We suggest that the C allele might have a masking effect on the G allele when both alleles are present in heterozygous individuals. However, we did not observe any significant association of the homozygous C allele with the onset of SLE or with protection from the disease (chi(2) = 1.684; P = 0.194366).


Assuntos
Interleucina-6/genética , Lúpus Eritematoso Sistêmico/genética , Adolescente , Adulto , Estudos de Casos e Controles , Feminino , Frequência do Gene , Homozigoto , Humanos , Interleucina-6/sangue , Lúpus Eritematoso Sistêmico/sangue , Malásia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Polimorfismo de Nucleotídeo Único/genética , Regiões Promotoras Genéticas , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA